When used consistently, these medications slow down digestion and enhance feelings of fullness, helping individuals naturally reduce calorie intake without feeling deprived
The trial demonstrated that semaglutide significantly reduced the risk of a major kidney event, including kidney failure, a 50% or greater reduction in estimated glomerular filtration rate (eGFR), or death from kidney-related or cardiovascular causes, in patients with CKD and Type 2 diabetes
Veniant, M
Increased regulation could also address potential conflicts of interest and anti-competitive practices
Association of bariatric surgery with cardiovascular outcomes in adults with severe obesity and nonalcoholic fatty liver disease
One potential side effect of GLP-1s is acid reflux, which can be uncomfortable enough that some people decide it isnt the right option for them, says Dr